Clinical trial
Destination Therapy Post Approval Study
NCT03681210 is registered in ClinicalTrials.gov with Medtronic Cardiac Rhythm and Heart Failure as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Destination Therapy Post Approval Study
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart Failure
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- October 31, 2018
- Completion date
- April 30, 2026
- Enrollment
- 300 (actual)
- Sites
- 47
Conditions
As the registry lists them; a condition with its own page is linked.
chronic heart failure